69 related articles for article (PubMed ID: 3067720)
1. The use of low-dose methotrexate for the treatment of allograft rejection is associated with significant drug toxicity.
Robinson JA; Costanzo-Nordin MR; Grusk BB; Silver MA; Sobotka PA; O'Connell JB; Pifarre R
Bibl Cardiol; 1988; (43):35-8. PubMed ID: 3067720
[No Abstract] [Full Text] [Related]
2. Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
Chan GL; Weinstein SS; Vijayanagar RR
Clin Transplant; 1995 Apr; 9(2):106-14. PubMed ID: 7599398
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda.
Chinnock R; Emery J; Larsen R; Baum M; Janner D; Razzouk A; Gundry S; Nehlsen-Cannarella S; Bailey L
J Heart Lung Transplant; 1995; 14(4):726-33. PubMed ID: 7578182
[TBL] [Abstract][Full Text] [Related]
4. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
6. [Effect promoting the rejection of an allograft of skin in rabbits treated with a high dose of amethopterin].
Lanza V; Losacco T; Garasto GF; Giorgi DA
Chir Ital; 1983 Aug; 35(4):514-8. PubMed ID: 6395972
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate for rejection prophylaxis after heart transplantation.
Taylor DO; Olsen SL; Ensley RD; Renlund DG
J Heart Lung Transplant; 1995; 14(5):950-4. PubMed ID: 8800732
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate for lung transplant recipients with steroid-resistant acute rejection.
Cahill BC; O'Rourke MK; Strasburg KA; Savik K; Jessurun J; Bolman RM; Hertz MI
J Heart Lung Transplant; 1996 Nov; 15(11):1130-7. PubMed ID: 8956122
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
Yu C; Storb R; Deeg HJ; Graham TC; Scheuning FG; Huss R; Seidel K; Fitzsimmons WE
Bone Marrow Transplant; 1996 Apr; 17(4):649-53. PubMed ID: 8722370
[TBL] [Abstract][Full Text] [Related]
10. Diminished cytotoxic gene expression in rat cardiac transplants with low-dose cyclosporine/methotrexate combination therapy.
Pizarro TT; Malinowska K; Kovacs EJ; Clancy J; Robinson JA; Piccinini LA
Transplantation; 1994 Jul; 58(2):223-32. PubMed ID: 8042241
[TBL] [Abstract][Full Text] [Related]
11. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
[TBL] [Abstract][Full Text] [Related]
12. Management of cyclosporine toxicity by reduced dosage and azathioprine.
Griffith BP; Hardesty RL; Lee A; Trento A; Thompson ME; Shapiro AP; Bahnson HT
J Heart Transplant; 1985; 4(4):410-3. PubMed ID: 3916516
[TBL] [Abstract][Full Text] [Related]
13. Association between blood eosinophil counts and acute cardiac and pulmonary allograft rejection.
Trull A; Steel L; Cornelissen J; Smith T; Sharples L; Cary N; Stewart S; Large S; Wallwork J
J Heart Lung Transplant; 1998 May; 17(5):517-24. PubMed ID: 9628572
[TBL] [Abstract][Full Text] [Related]
14. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
15. Long-term bone marrow culture as a model for host toxicity: the effect of methotrexate on hematopoiesis and adherent layer function.
Williams LH; Udupa KB; Lipschitz DA
Exp Hematol; 1988 Jan; 16(1):80-7. PubMed ID: 3257191
[TBL] [Abstract][Full Text] [Related]
16. Treatment of moderate heart allograft rejection with cyclosporine.
Radovancevic B; Frazier OH
J Heart Transplant; 1986; 5(4):307-11. PubMed ID: 3114444
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate therapy in pediatric heart transplantation as treatment of recurrent mild to moderate acute cellular rejection.
Shaddy RE; Bullock EA; Tani LY; Orsmond GS; Olsen SL; Taylor DO; McGough EC; Hawkins JA; Renlund DG
J Heart Lung Transplant; 1994; 13(6):1009-13. PubMed ID: 7865506
[TBL] [Abstract][Full Text] [Related]
18. The effect of methotrexate on granulocytic stem cells and granulopoiesis.
Vogler WR; Mingioli ES; Garwood FA
Cancer Res; 1973 Jul; 33(7):1628-33. PubMed ID: 4721225
[No Abstract] [Full Text] [Related]
19. Differential white cell count relationships with human cardiac allograft rejection.
Healy DG; Watson RW; Fitzpatrick JM; Wood AE
Transplant Proc; 2007; 39(1):218-22. PubMed ID: 17275509
[TBL] [Abstract][Full Text] [Related]
20. [No effect of particular r-RNA fragments on cytostatic-induced myelosuppression in a rat transplanted tumor model].
Berger M; Zeller WJ
Arzneimittelforschung; 1983; 33(10):1477-8. PubMed ID: 6686049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
